Expert Review of Neurotherapeutics

Article	Citations
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men	46
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study	40
Where Art Thou O treatment for diabetic neuropathy: the sequel	40
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?	40
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease	38
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis	34
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms	28
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review	27
The relevance of cortical thickness in migraine sufferers and implications to therapy	26
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 2025	26
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis	25
Advances in the treatment and management of frontotemporal dementia	25
Steps to manage treatment-refractory migraine in adults	25
The latest developments with internet-based psychological treatments for depression	24
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives	24
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options	23
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?	23
Why is ADHD so difficult to diagnose in older adults?	23
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents	22
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia	22
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead	21
Acute and long-term cognitive impairment following sepsis: mechanism and prevention	20
Hesitancies in primary headaches treatments	19
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor	19
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder	19

Correction	19
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension	18
Epilepsy surgery for seizure control in individuals with Dravet syndrome: is it a safe and practical option?	18
Mindfulness as a therapeutic option for obsessive-compulsive disorder	18
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan	18
Electroconvulsive therapy in patients with trauma and personality disorders: what is the evidence?	18
Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature	18
Spinal automaticity of movement control and its role in recovering function after spinal injury	18
Emerging role for radiomics in the management of intracranial arteriovenous and cavernous malformations	18
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms	17
Advances in the early diagnosis of amyotrophic lateral sclerosis	17
Virtual reality technology in the treatment of anxiety – progress and future challenges	17
Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients	16
Diagnostic advances and challenges in meningioma	16
Multimodal approaches to the treatment of personality disorder	16
Current perspectives on the diagnosis, assessment, and management of vasculitic neuropathy	16
Current use of neurotoxins for alleviating symptoms of cervical dystonia	16
Considerations for hormonal therapy in migraine patients: a critical review of current practice	15
The differential diagnosis of autism spectrum disorder in adults	15
Persistent post-concussion syndrome: pathophysiology, diagnosis, current and evolving treatment strategies	15
The impact of sleep apnea on epilepsy treatment outcomes	15
Advances in gene therapy for high-grade glioma: a review of the clinical evidence	15
Illuminating the way: the role of bright light therapy in the treatment of depression	15
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound	15
Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review	15
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools	15
A novel treatment option for intrajejunal levodopa administration	15
Long-term outcomes in refractory status epilepticus	14
Cross-national reflections on medicinal cannabis and depression	14
Advancements in neuroactive peptides in seizures	14
Developing personalized treatment strategies for Parkinson’s disease based on disease subtypes	14
Advances in the diagnosis of pediatric arterial ischemic stroke – imaging and beyond	13
Considering hearing loss as a modifiable risk factor for dementia	13
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective	13
Pathogenesis of comorbid epilepsy in Alzheimer’s disease and use of perampanel, an AMPA receptor inhibitor	13
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature	13
Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)	13
The effectiveness of electroconvulsive therapy (ECT) for people with bipolar disorder: is there a specific role?	13
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts	13
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France	13
Frontotemporal dementia. How to deal with its diagnostic complexity?	13
Updated review of rescue treatments for seizure clusters and prolonged seizures	12
Profiling aducanumab as a treatment option for Alzheimer’s disease: an overview of efficacy, safety and tolerability	12
Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson’s disease	12
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?	12
Could self-reporting sleep duration become an important tool in the prediction of dementia?	11
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes	11
Novel approaches for the treatment of frontotemporal dementia: is there hope for the future?	11
Therapeutic issues in Guillain–Barré syndrome	11
Medication-overuse headache: can anti-CGRP monoclonal antibodies replace withdrawal?	11

Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence	11
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper	11
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions	11
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression	11
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis	11
Bipolar disorder staging and the impact it has on its management: an update	11
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?	11
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain	11
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions	11
Rethinking the role of trazodone in the different depressive dimensions	10
Long-term central nervous system (CNS) consequences of COVID-19 in children	10
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions	10
Stem cell therapy for patients with paraplegia: is there hope for the future?	10
Developments in targeting calcitonin gene-related peptide	10
Contemporary perspectives in cerebral amyloid angiopathy	10
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review	10
Meniere disease subtyping: the direction of diagnosis and treatment in the future	9
The pivotal role of central sensitization in long COVID, fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome	9
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis	9
Important context missing from “contemporary perspectives in cerebral amyloid angiopathy”	9
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease	9
Cognitive or daily stress association with headache and pain induction in migraine and tension-type headache patients: a systematic review	9
Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis	9
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?	9
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations	9
Risk of suicide and suicide-related events in subjects treated with antiseizure medications	9
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions	9
Is transcranial direct current stimulation a viable treatment option for fibromyalgia?	8
Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?	8
The complexities in the differential diagnosis of restless legs syndrome (Willis–Ekbom disease)	8
What are the main challenges in the treatment of neonatal hypoxic ischemic encephalopathy?	8
Learnings in developmental and epileptic encephalopathies: what do we know?	8
Contemporary diagnosis and treatment of conduct disorder in youth	8
The major challenges with pharmacologic management of chronic traumatic encephalopathy	8
Tobacco use disorder and depression: emerging strategies and recommendations:	8
Suicide and suicidal behaviors: insight into clinical challenges and preventive measures	8
Deep brain stimulation: new programming algorithms and teleprogramming	8
Insulin signaling in the central nervous system, a possible pathophysiological mechanism of anesthesia-induced delayed neurocognitive recovery/postoperative neurocognitive disorder: a narrative review	8
The challenges and opportunities related to the therapeutic use of music in psychiatry	8
Ublituximab-xiiy as a treatment option for relapsing multiple sclerosis	8
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease	8
Superior treatment efficacy of neuromodulation rehabilitation for upper limb recovery after stroke: a meta-analysis	7
An update on pharmacotherapy for trigeminal neuralgia	7
Letter to the editor: reflections on the future of medical cannabis research for depression	7
A plain language summary of the SAPPHIRE clinical trial of apitegromab in children and young adults with spinal muscular atrophy	7
The treatment of restless legs syndrome and periodic limb movement disorder: a plain language summary of the American Academy of Sleep Medicine Clinical Practice Guidelines	7
Current and emerging therapies for autoimmune encephalitis	7
The value of radiotherapy in patients with recurrent atypical meningioma: an update	7
Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments	7
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment	7
The burden of migraine in Mexico: a database analysis of migraine-related visits to emergency departments in Mexico’s Ministry of Health (MMoH) hospitals	7
Advances in stem cell-based therapeutic transfers for glioblastoma treatment	7
Pharmacological strategies for treating social anxiety disorder in adults: a systematic review of studies published since 2015	7
A proposal for a shared therapeutic algorithm in children with prolonged convulsive seizures and status epilepticus	7
Re-evaluating the prognosis of schizophrenia: tackling the issue of inadequate treatment	7
Pharmacological approaches to the management of panic disorder in older patients: a systematic review	7
Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders	7
Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients	7
The changing landscape of neuroimaging in frontotemporal lobar degeneration: from group-level observations to single-subject data interpretation	7
Considerations for the treatment of obsessive-compulsive disorder in patients who have comorbid major depression	6
Optimizing cognitive behavioral therapy to treat anxiety among youth with autism spectrum disorders	6
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry	6
An update on the comorbidity of attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) and its clinical management	6
Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review	6
Is it possible to prevent relapse in panic disorder?	6
Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial	6
Insights into headache 2022	6
Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agent	6
Neuromodulation as a therapeutic approach for post-traumatic stress disorder: the evidence to date	6
When is pharmacological intervention recommended for adults with social anxiety disorder?	6
What impact can brain stimulation interventions have on borderline personality disorder?	6
Obtaining long-term recovery: advances in optimizing treatment outcomes in patients with binge-eating disorder	6
Mobile health technologies for the management of Parkinson’s disease	6
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes	6
Precision pain management: can delta opioid receptor (DOR) agonists outperform more traditional pain management strategies?	6
Imaging of congenital and developmental cystic lesions of the brain: a narrative review	6
Central vestibular dysfunction: don’t forget vestibular rehabilitation	6
Expert guidance on the differential diagnosis of neuroleptic malignant syndrome	6
Updated perspectives on how and when lithium should be used in the treatment of mood disorders	6
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis	6

Emerging antibody-based therapies for Huntington’s disease: current status and perspectives for future development	6
The latest views on how vagus nerve stimulation works in epilepsy: a plain language summary	6
Paroxysmal sympathetic hyperactivity (PSH) after traumatic brain injury: the pathophysiological role of glutamate and potential treatment with branched-chain amino acids	5
Evaluating the adenosine hypothesis of restless legs syndrome and its implications for current and future treatment strategies	5
Why does exposure-based therapy fail in some individuals with obsessive-compulsive disorder?	5
How does “Pure-O” obsessive-compulsive disorder impact on a patient’s treatment plan?	5
Clinical considerations for rapid administration of undiluted or minimally diluted levetiracetam bolus doses	5
The promise and challenges of transcranial magnetic stimulation and deep brain stimulation as therapeutic options for obsessive-compulsive disorder	5
Challenges in the treatment of dysthymia: a narrative review	5
A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder	5
Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?	5
Managing symptoms and improving the quality of life of persons with Machado-Joseph disease	5
Speech and language outcome measures in clinical trials of Alzheimer’s and Parkinson’s diseases	5
Correlation between systemic bleeding during thrombolysis and intracranial hemorrhage after thrombolysis in acute ischemic stroke	5
Current perspectives on the diagnosis and management of acute transverse myelitis	5
Pharmacological options for narcolepsy: are they the way forward?	5
Effectiveness of virtual reality rehabilitation with exergames on functional rehabilitation in Parkinson’s disease: a systematic review of chronic randomized controlled trials	5
The advances in the early and accurate diagnosis of Creutzfeldt–Jakob disease and other prion diseases: where are we today?	5
Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond	5
Comparative effectiveness of atogepant and rimegepant for migraine prevention in Japanese patients: an anchored matching-adjusted indirect comparison	5
UK Medical Cannabis Registry: a cohort study of patients prescribed cannabis-based oils and dried flower for generalised anxiety disorder	5
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant	5
Therapeutic barriers for headache management: issues facing the global north and global south in 2024	5
Advances in the systemic therapy for recurrent meningiomas and the challenges ahead	5
Assessing cognitive impairment among pediatric epilepsies: a systematic review	5
Acute and prophylactic treatment of dialysis headache: a systematic review	4
The utility of magnetoencephalography in epilepsy and its implications for treatment	4
Evaluating clazosentan sodium for the treatment of aneurysmal subarachnoid hemorrhage	4
Careful considerations for the treatment of posttraumatic stress disorder during and following pregnancy	4
Risk factors and disease associations in people living with idiopathic intracranial hypertension	4
The impact of cognitive reserve relative to risk of Alzheimer’s disease and rate of progression: an up-to-date review of the literature	4
Trichotillomania and its treatment: an updated review and recommendations	4
How could brain fingerprinting lead to the early detection of mental illness in adolescents and what are the next steps?	4
New trends in the treatment of blepharospasm: replacing the standardized approach with a personalized approach	4
Rethinking the medication management of major depression	4
Accelerating the development of noninvasive brain stimulation devices: using design thinking to facilitate its clinical use and acceptance	4
How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson’s disease?	4
An overview of the utility of prasugrel hydrochloride as a treatment option for ischemic stroke	4
Can pharmacotherapy help to reduce trichotillomania?	4
Emerging frontiers in Chronic Traumatic Encephalopathy: early diagnosis and implications for neurotherapeutic interventions	4
Stereotaxic-assisted gene therapy in Alzheimer’s and Parkinson’s diseases: therapeutic potentials and clinical frontiers	4
Are ketamine and its enantiomers the answer to treatment-refractory depression?	4
Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: post-hoc analysis of a prospective, real-world Greek registry	4
An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents	4
Can regular physical exercise be a treatment for panic disorder? A systematic review	4
Adapting psychedelic medicine for headache and chronic pain disorders	4
Withdrawal of antiseizure medications – for whom, when, and how?	4
Guidance on antipsychotic selection for agitation and aggressive behavior in persons with Huntington’s disease	4
Essential tremor - drug treatments present and future	4
Rimegepant for the acute and preventive treatment of migraine: a narrative review of the evidence	4
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome	4
Brain atrophy assessment in multiple sclerosis: technical– and subject-related barriers for translation to real-world application in individual subjects	4
Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience	4
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis	3
The importance of synthetic pharmacotherapy for recessive cerebellar ataxias	3
Exploring the natural age cutoff point for primary-progressive multiple sclerosis therapy	3
Preventing recurrence of postpartum depression by regulating sleep	3
The latest advances in the pharmacological management of focal epilepsies in children: a narrative review	3
Updated strategies for the management of poor medication adherence in patients with bipolar disorder	3
Advances in the treatment of familial dysautonomia: what does the future hold?	3
Current perspectives on the clinical management of cryptogenic stroke	3
Impact of psychiatric comorbidities on the treatment of epilepsies in adults	3
Emerging biomarkers to predict clinical outcomes in Guillain–Barré syndrome	3
Therapeutic strategies that modulate the acute phase of secondary spinal cord injury scarring and inflammation and improve injury outcomes	3
Current and emerging treatment options for Angelman syndrome	3
Real world considerations for newly approved CGRP receptor antagonists in migraine care	3
Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection	3
Viltolarsen: a treatment option for Duchenne muscular dystrophy patients who are amenable to exon 53 skipping therapy	3
Suicidality and antiepileptic drugs in people with epilepsy: an update	3
Seizure medication and planned pregnancy: balancing the risks and outcomes	3
Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper	3
Unlocking the potential of virtual reality for post-stroke sensorimotor rehabilitation - are we any closer?	3
Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome	3
Managing cognitive impairment in Parkinson’s disease: an update of the literature	3
Zonisamide oral suspension as adjunctive therapy for treating partial seizures in adults and in pediatric patients aged 16 years and older with epilepsy	3
The management of neurofibromatosis type 1 (NF1) in children and adolescents	3
An evaluation of onobotulinumtoxinA as a therapeutic option for pediatric neurogenic detrusor overactivity	3
Redefining insomnia: from neural dysregulation to personalized therapeutics	3
Overcoming barriers to the management of seizure clusters: ease of use and time to administration of rescue medications	3
Overcoming clinical challenges of refractory neuropathic pain	3
The early recognition and diagnosis of neoplastic meningitis	3
Status epilepticus in pregnancy: a literature review and a protocol proposal	3
Evaluating the efficacy and safety of the currently available once-every-two months long-acting injectable formulations of aripiprazole for the treatment of schizophrenia or as a maintenance monothera	3
An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?	3
Progress, development, and challenges in amyotrophic lateral sclerosis clinical trials	3
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder	3
Pharmacological interventions to improve sleep in people with Alzheimer’s disease: a meta-analysis of randomized controlled trials	3
The involvement of the microbiota-gut-brain axis in the pathophysiology of mood disorders and therapeutic implications	3
Nanomaterials in neuromodulation: what is the potential?	3
Transcranial direct-current stimulation of the prefrontal cortex enhances working memory and suppresses pathological gamma power elevation in schizophrenia	3
The human functional connectome in neurodegenerative diseases: relationship to pathology and clinical progression	3